tiprankstipranks
Trending News
More News >
HemoGenyx Pharmaceuticals Plc (GB:HEMO)
LSE:HEMO
UK Market

HemoGenyx Pharmaceuticals Plc (HEMO) Income Statement

Compare
18 Followers

HemoGenyx Pharmaceuticals Plc Income Statement

Last quarter (Q4 2024), HemoGenyx Pharmaceuticals Plc's total revenue was £0.00, a decrease of ― from the same quarter last year. In Q4, HemoGenyx Pharmaceuticals Plc's net income was £-2.81M. See HemoGenyx Pharmaceuticals Plc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
£ 0.00£ 0.00£ 0.00£ 0.00£ 0.00
Gross Profit
£ -639.28K£ -645.68K£ -2.60M£ -283.65K£ -350.72K
Operating Expenses
£ 5.09M£ 4.91M£ 2.93M£ 2.55M£ 1.87M
Depreciation and Amortization
£ 639.28K£ 645.68K£ 564.07K£ 126.34K£ 106.75K
EBITDA
£ -4.71M£ -5.73M£ -3.42M£ -2.39M£ -1.96M
Operating Income
£ -5.73M£ -5.56M£ 4.00M£ -2.70M£ -2.15M
Other Income/Expenses
£ 101.22K£ -1.14M£ 10.57K£ -2.41M£ 55.36K
Pretax Income
£ -5.63M£ -6.70M£ -3.99M£ -5.11M£ -2.10M
Net Income
£ -5.62M£ -6.69M£ -4.35M£ -7.52M£ -2.12M
Per Share Metrics
Basic EPS
£ -1.70£ -2.37£ 0.00£ -0.01£ -0.01
Diluted EPS
£ -1.70£ -2.37£ 0.00£ -0.01£ -0.01
Weighted Average Shares Outstanding
3.30M 2.82M 979.75M 773.95M 414.83M
Weighted Average Shares Outstanding (Diluted)
3.30M 2.82M 979.75M 773.95M 414.83M
Currency in GBP

HemoGenyx Pharmaceuticals Plc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis